GlassScriptPhysician profile
Winston Scott
NPI 1780729921
$3,463.88
in general payments reported to CMS, 2019-2025
19 companies · $1,038 in 2025
The $1,038 reported for 2025 was more than what 88% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $282 · 2020: $152 · 2021: $652 · 2022: $318 · 2023: $328 · 2024: $695 · 2025: $1,038.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,061.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,060.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sight Sciences, INC. | $666.84 | 2021-2025 | Omni Surgical System, Sion Surgical Instrument |
| Bausch & Lomb Americas INC. | $520.67 | 2022-2025 | Vyzulta, Envista Mx60 Iol, Miebo |
| Abbvie INC. | $518.85 | 2022-2025 | Vuity, Alphagan P, Lumigan |
| Allergan, INC. | $417.35 | 2019-2021 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $240.26 | 2019-2021 | |
| Aerie Pharmaceuticals, INC. | $236.37 | 2019-2021 | |
| Tarsus Pharmaceuticals, INC. | $215.52 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $200.16 | 2022-2025 | Rocklatan, Simbrinza |
| Glaukos Corporation | $111.09 | 2025 | Idosetr |
| Biotissue Holdings INC. | $109.77 | 2023-2025 | |
| Oyster Point Pharma, INC. | $63.68 | 2022-2025 | Tyrvaya, Ryzumvi |
| Axogen | $38.00 | 2025 | |
| Novartis Pharmaceuticals Corporation | $27.61 | 2020-2022 | |
| Rayner Intraocular Lenses Limited | $17.49 | 2024 | Rayone Spheric, Rayone Aspheric, Rayone Emv |
| Amgen INC. | $17.18 | 2024 | Tepezza |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kala Pharmaceuticals, INC. | $16.30 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $16.11 | 2025 | Abilify Maintena |
| Ocular Therapeutix, INC. | $15.63 | 2023 | Dextenza |
| Mallinckrodt Hospital Products INC. | $15.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Winston Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.